Fresenius Kabi To Push Up Parenteral Volumes

The Pune-based Fresenius Kabi India Pvt. Ltd, a wholly owned subsidiary of the Germany-based Fresenius Kabi AG, is planning to expand its operations in India both through organic and inorganic means. Now more than a Rs 100 crore company in India, Fresenius Kabi has established its mark as a leading provider of plasma volume expanders and parenteral nutrition solutions.

Speaking to Chronicle Pharmabiz, Rakesh Bhargava, managing director and chief executive officer, Fresenius Kabi India Pvt. Ltd, said, "Presently, the company is expanding its operations in China. Once Fresenius Kabi establishes itself as a countable force in China, the company will turn its focus to India. The company will resort to both organic and inorganic ways to expand its reach and establish itself as a major player in the country."

As part of the company's initiatives to conquer the Indian pharma market with new products, Fresenius Kabi has recently launched blood banking products and enteral nutrition powder diets in the country. Apart, the company has also introduced a couple of parenteral and enteral nutrition packages in the country and is a major player in this segment of business.

Also, the company is one of the major players in the infusion therapy with a wide range of products, including infusion solutions for osmotic therapy and blood volume replacement and hemodilution therapy, I.V. anaesthetics, I.V. anti-infective drugs, irrigation solutions or urology and other basic solutions. The company also provides medical devices related to this segment, including PDMS patient data management systems, volumetric infusion pumps and syringe pumps, infusion and clinical fluid management systems, IV anaesthesia and analgesia systems and autotrans-fusion systems.

(Ref: The Chronicle Pharmabiz Dated July 12, 2007)